Vaccines have basically worked the same way for decades. A pathogen antigen is isolated, used as the basis of a vaccine and administered to the patient. The Pentagon thinks there might be a better way of doing things, and it has tasked Pfizer with investigating its hunch.
The U.S. Department of Defense is launching a $70 million project involving the use of a brain monitoring implant to help soldiers better manage depression, stress and other related conditions.
President Barack Obama plans to roll out a highly anticipated brain mapping project today, providing details about the ambitious initiative to uncover mysteries about complex brain functions that could lead to new therapies for Alzheimer's and Parkinson's diseases.
A unit of the U.S. Department of Defense has challenged the Foldit video gamers to craft proteins in a virtual online setting that bind to pathogens in the blood, to bolster research of sepsis treatments.
It will come as no surprise to anyone in the business of drug development and translational research to hear that animal studies suffer from severe shortcomings. The traditional mouse study often can't detect the kind of simple toxicities that will scuttle a program later on.
The National Institutes of Health is moving ahead with a $70 million initiative to promote the development of tissue chips for drug research, a hybrid of computers and tissue engineering that could give scientists a viable alternative to the use of animals in preclinical trials.
Vaccine seeding is under way at Medicago's new 97,000-square-foot, plant-based vaccine facility in Research Triangle Park, NC. Less than a year after groundbreaking, the production of vaccines based
The Defense Advanced Research Projects Agency, or DARPA, is funneling $1.3 million to researchers at the University of Michigan to see if they can use nanoparticles to transform the way morphine is